{"id":"https://openalex.org/W2052227976","doi":"https://doi.org/10.1093/europace/euu239.3","title":"33 * Patterns of antithrombotic therapy in relation to type of atrial fibrillation: insights from the UK cohort of the global GARFIELD registry","display_name":"33 * Patterns of antithrombotic therapy in relation to type of atrial fibrillation: insights from the UK cohort of the global GARFIELD registry","publication_year":2014,"publication_date":"2014-10-01","ids":{"openalex":"https://openalex.org/W2052227976","doi":"https://doi.org/10.1093/europace/euu239.3","mag":"2052227976"},"language":"en","primary_location":{"id":"doi:10.1093/europace/euu239.3","doi":"https://doi.org/10.1093/europace/euu239.3","is_oa":false,"landing_page_url":"https://doi.org/10.1093/europace/euu239.3","pdf_url":null,"source":{"id":"https://openalex.org/S46732370","display_name":"EP Europace","issn_l":"1099-5129","issn":["1099-5129","1532-2092"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Europace","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029526188","display_name":"Patricia N Apenteng","orcid":"https://orcid.org/0000-0003-0835-3495","observed_orcids":["https://orcid.org/0000-0003-0835-3495","https://orcid.org/0000-0002-7012-6560"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P. N. Apenteng","raw_affiliation_strings":["University of Birmingham, Birmingham","Univ. of Birmingham, Birmingham#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham, Birmingham","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"Univ. of Birmingham, Birmingham#TAB#","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042199144","display_name":"Ellen T Murray","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"E. T. Murray","raw_affiliation_strings":["University of Birmingham, Birmingham","Univ. of Birmingham, Birmingham#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham, Birmingham","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"Univ. of Birmingham, Birmingham#TAB#","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008167189","display_name":"Richard F. Hobbs","orcid":"https://orcid.org/0000-0001-7976-7172","observed_orcids":["https://orcid.org/0000-0001-7976-7172"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"F. D. R. Hobbs","raw_affiliation_strings":["University of Oxford, Oxford","University of Oxford\u2028Oxford"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oxford, Oxford","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"University of Oxford\u2028Oxford","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109286729","display_name":"A. K. Kakkar","orcid":"https://orcid.org/0000-0002-0031-2704","observed_orcids":["https://orcid.org/0000-0002-0031-2704"]},"institutions":[{"id":"https://openalex.org/I4210139260","display_name":"Thrombosis Research Institute","ror":"https://ror.org/050r8mq79","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210139260"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. K. Kakkar","raw_affiliation_strings":["Thrombosis Research Institute, London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thrombosis Research Institute, London","institution_ids":["https://openalex.org/I4210139260"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059773134","display_name":"David Andrew Fitzmaurice","orcid":"https://orcid.org/0000-0002-9104-6252","observed_orcids":["https://orcid.org/0000-0002-9104-6252"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. A. Fitzmaurice","raw_affiliation_strings":["University of Birmingham, Birmingham","Univ. of Birmingham, Birmingham#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham, Birmingham","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"Univ. of Birmingham, Birmingham#TAB#","institution_ids":["https://openalex.org/I79619799"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4344,"currency":"EUR","value_usd":4909},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"suppl 3","first_page":"iii14","last_page":"iii14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.9700000286102295},{"id":"https://openalex.org/keywords/oral-anticoagulation","display_name":"oral anticoagulation","score":0.9660000205039978},{"id":"https://openalex.org/keywords/antithrombotic-therapy","display_name":"antithrombotic therapy","score":0.9480000138282776},{"id":"https://openalex.org/keywords/stroke-risk","display_name":"stroke risk","score":0.6380000114440918},{"id":"https://openalex.org/keywords/chads2-score","display_name":"CHADS2 score","score":0.9909999966621399},{"id":"https://openalex.org/keywords/paroxysmal-atrial-fibrillation","display_name":"paroxysmal atrial fibrillation","score":0.9819999933242798},{"id":"https://openalex.org/keywords/persistent-atrial-fibrillation","display_name":"persistent atrial fibrillation","score":0.9940000176429749},{"id":"https://openalex.org/keywords/permanent-atrial-fibrillation","display_name":"permanent atrial fibrillation","score":0.9940000176429749},{"id":"https://openalex.org/keywords/underuse-of-anticoagulation","display_name":"underuse of anticoagulation","score":0.5979999899864197},{"id":"https://openalex.org/keywords/practice-patterns","display_name":"clinical practice patterns","score":0.44600000977516174},{"id":"https://openalex.org/keywords/garfield-af-registry","display_name":"GARFIELD-AF registry","score":0.9110000133514404},{"id":"https://openalex.org/keywords/stroke-prevention","display_name":"stroke prevention","score":0.4650000035762787},{"id":"https://openalex.org/keywords/guideline-adherence","display_name":"guideline adherence","score":0.5350000262260437},{"id":"https://openalex.org/keywords/uk-patients","display_name":"UK patients","score":0.47600001096725464},{"id":"https://openalex.org/keywords/newly-diagnosed-atrial-fibrillation","display_name":"newly diagnosed atrial fibrillation","score":0.6880000233650208}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9685076475143433},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.8657087087631226},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.6608483791351318},{"id":"https://openalex.org/C2777015399","wikidata":"https://www.wikidata.org/wiki/Q4775337","display_name":"Antithrombotic","level":2,"score":0.601296603679657},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5357387065887451},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5331907272338867},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5326967239379883},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5300151109695435},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.45886585116386414},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.45065566897392273},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4317336976528168},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.42527303099632263},{"id":"https://openalex.org/C2780084366","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demographics","level":2,"score":0.41188663244247437},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3372538685798645},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.06602004170417786},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/europace/euu239.3","doi":"https://doi.org/10.1093/europace/euu239.3","is_oa":false,"landing_page_url":"https://doi.org/10.1093/europace/euu239.3","pdf_url":null,"source":{"id":"https://openalex.org/S46732370","display_name":"EP Europace","issn_l":"1099-5129","issn":["1099-5129","1532-2092"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Europace","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.7200000286102295}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2030717199","https://openalex.org/W2611557181","https://openalex.org/W148041586","https://openalex.org/W2066751879","https://openalex.org/W3024094360","https://openalex.org/W2350791141","https://openalex.org/W4290748932","https://openalex.org/W4235252973","https://openalex.org/W2128797028","https://openalex.org/W2943855382"],"abstract_inverted_index":{"Evidence":[0],"based":[1],"atrial":[2,14,30],"fibrillation":[3,15],"(AF)":[4],"management":[5],"guidelines":[6],"recommend":[7],"oral":[8],"anticoagulation":[9,396],"(OAC)":[10],"for":[11,112,145,192,207,397,428],"patients":[12,51,103,121,125,264,301,309,315,326,339,353,398,421],"with":[13,52,104,272,302,310,327,338,340,354,358,405,433],"at":[16,105,153,163,316],"moderate":[17],"to":[18,42,85,117,135,225,333,387,409],"high":[19,268,317],"risk":[20,39,110,202,269,318,404],"of":[21,27,29,44,50,81,89,99,148,171,180,211,232,262,270,276,281,291,296,319,323,352,361,376,395,411,423,425],"stroke":[22,38,271,320,403],"and":[23,87,122,140,160,183,242,283,306,344,391],"without":[24],"contraindications":[25],"regardless":[26],"type":[28,43,88,170,375,424],"fibrillation.":[31],"The":[32,114,131,402],"literature":[33],"suggests":[34,369],"a":[35,47,73,146,187,267,273,279,288],"misconception":[36,64],"about":[37],"in":[40,46,66,126,219,300,308,399,431],"relation":[41],"AFresulting":[45],"significant":[48],"proportion":[49],"paroxysmal":[53,245,311,328,382,406],"AF":[54,75,102,172,176,195,241,304,312,329,342,357,383,413,420],"not":[55,197,255],"receiving":[56],"prophylactic":[57],"anticoagulation.":[58],"It":[59],"is":[60,93,133,166,372,416],"unclear":[61],"if":[62],"this":[63,400],"persists":[65],"clinical":[67],"practice.":[68],"Using":[69],"UK":[70,227,367],"data":[71],"from":[72],"global":[74],"registry":[76,98,115],"we":[77],"investigated":[78],"the":[79,174,220,226,233,247,263,284,294],"use":[80,295,371,430],"antithrombotic":[82],"therapy":[83],"according":[84],"CHADS2score":[86],"AF.":[90,258,377],"Methods:":[91],"GARFIELD-AF":[92],"an":[94],"on-going,":[95],"observational,":[96],"international":[97],"newly":[100],"diagnosed":[101],"least":[106,307,331,385],"one":[107,214],"additional":[108],"investigator-determined":[109],"factor":[111],"stroke.":[113],"aims":[116],"enrol":[118,136],"50,000":[119],"prospective":[120],"5000":[123],"retrospective":[124],"five":[127],"independent,":[128],"sequential":[129],"cohorts.":[130],"study":[132],"designed":[134],"consecutive":[137],"eligible":[138],"patients,":[139],"participants":[141,234],"are":[142],"followed":[143],"up":[144],"minimum":[147],"2":[149],"years.":[150],"Data":[151,165],"collected":[152,168],"baseline":[154],"include":[155],"patient":[156],"demographics,":[157],"medical":[158],"history,":[159],"treatments":[161],"initiated":[162],"diagnosis.":[164],"also":[167],"on":[169],"using":[173],"current":[175],"classification":[177,189],"scheme":[178],"consisting":[179],"paroxysmal,":[181],"persistent,":[182],"permanent":[184,236,341,412],"AF,":[185,237],"plus":[186],"fourth":[188],"\u2018new":[190],"AF\u2019":[191],"cases":[193],"where":[194],"has":[196],"yet":[198,256],"been":[199],"classified.":[200],"Stroke":[201],"scores":[203],"were":[204,217,250,330,384],"calculated":[205],"retrospectively":[206],"CHADS2.":[208],"Results:":[209],"Out":[210],"10,614":[212],"cohort":[213],"participants,":[215],"397":[216],"enrolled":[218],"UK.":[221],"These":[222],"results":[223],"relate":[224],"population.":[228],"Approximately":[229],"half":[230,350],"(49.6%)":[231],"had":[235,239,244,266,287],"12.1%":[238],"persistent":[240,303,345],"18.9%":[243],"AF;":[246],"remaining":[248,285],"19.4%":[249],"classed":[251],"as":[252,380],"\u2018new\u2019":[253,355],"or":[254],"classified":[257,379],"Almost":[259],"two":[260],"thirds":[261],"(62%)":[265],"CHADS2":[274,289,359],"score":[275,280,290,322,360],"\u2265":[277,324,362],"2;":[278],"1":[282],"4%":[286],"0.":[292],"Overall":[293],"OAC":[297,335,370,429],"was":[298,393],"greatest":[299],"(65.2%)":[305],"(44.8%).":[313],"In":[314],"(CHADS2":[321],"2)":[325],"likely":[332,386],"receive":[334,388],"(38.5%)":[336],"compared":[337],"(61.7%)":[343],"(63.6%).":[346],"Conversely":[347],"less":[348],"than":[349],"(47.2%)":[351],"unclassified":[356],"2received":[363],"OAC.":[364],"Implications:":[365],"This":[366],"dataset":[368],"influenced":[373],"by":[374],"Patients":[378],"having":[381],"anticoagulant":[389],"treatment":[390],"there":[392],"underutilisation":[394],"category.":[401],"AFis":[407],"comparable":[408],"that":[410,418],"therefore":[414],"it":[415],"important":[417],"all":[419],"irrespective":[422],"AFare":[426],"considered":[427],"accordance":[432],"guideline":[434],"recommendations.":[435]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}